1Halpern MT, Khan ZM, Schmier J K, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data [J]. Hypertension, 2006,47 (6) : 1039 - 1048.
2Haynes RB,Taylor DW,Sackett DL.Compliance in health care.Baltimore.Johns Hopkins Press,1979.1-7.
3Gil Val.Validity of 6 indirect methods to access treatment compliance in arterial hypertension.Med Clin Care,1994,102(14):532.
4Balazovjech I and Hnilica PJ.Complicance with antihypertensive treatment in consultation rooms for hypertensive patients.J Hum Hypertens,1993,7:581.
5Khalil SA and Elzubier AG.Drug compliance among hypertensive patients in Tabuk,Saudi Arebia.J Hypertension,1997,15(5):561.
6Medical Subject Headings (IM). National Institute of Health,1997,19(part2)1;XLⅡ.
7Cox DR, Fitzpatrick R, Fletcher AE, et al. Quality-of-life assessment: can we keep it simple?[J].J R Statist Soc,1992,155:353-393.
8Ormel J, Lindenberg S, Steverink N, et al. Quality of life and social production functions: a framework for understanding health effects[J].Soc Sci Med,1997,45:1051-1063.
9WHO QOL Group. Development of the World Health Organization WHO QOL-BREF quality of life assessment[J].Psychol Med.1998;28:551-558.
10Levine MN. Quality of life in stageⅡ breast cancer: an instrument for clinical trials[J].J Clin Oncol,1988,6:1798-1810.
5Bock A.The influence of salt intake on hypertension[J].Ther Um-sch,2009,66(11):721-724.
6Halpern MT,Khan ZM,Schmier JK,et al.Recommendations for eval-uating compliance and persistence with hypertension therapy using retrospective data[J].Hypertension,2006,47(6):1039-1048.
